• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ABLX:BB

9.2210 EUR 0.1610 1.78%

As of 09:11:35 ET on 12/22/2014.

Snapshot for Ablynx NV (ABLX)

Open: 9.1500 Day's Range: 9.0700 - 9.2500 Volume: 54,148
Previous Close: 9.0600 52wk Range: 6.8900 - 10.1800 1-Yr Rtn: +33.45%

Stock Chart for ABLX

No chart data available.
  • ABLX:BB 9.2480
  • 1D
  • 1M
  • 1Y
9.0600
Interactive ABLX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ABLX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. BEL20 -
Earnings Per Share (EUR) (ttm) -0.3200
Est. EPS (EUR) (12/2014) -0.2540
Est. PEG Ratio -
Market Cap (M EUR) 499.63
Shares Outstanding (M) 54.01
30 Day Average Volume 86,613
Price/Book (mrq) 11.0028
Price/Sale (ttm) 10.3670
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ABLX

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ABLX

Ablynx NV is a biopharmaceutical company. The Company discovers and develops therapeutic protein treatments for human diseases.

Edwin MosesChief Executive OfficerWim OttevaereChief Financial Officer
Johan HeylenChief Commercial OfficerJosefin-Beate Holz "Josi"Chief Medical Officer
More Company Profile & Key Executives for ABLX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil